Sondergaard Claus S, Haldrup Christa, Beer Christiane, Andersen Bente, Kohn Donald B, Pedersen Lene
Department of Molecular Biology, Aarhus University, 8000 Arhus, Denmark.
Hum Gene Ther. 2009 Apr;20(4):337-49. doi: 10.1089/hum.2008.140.
Retroviral vector-mediated gene transfer has been used successfully in clinical gene therapy. Cells of the hematopoietic lineages, however, remain difficult to transduce, although precoating of culture vessels with the fibronectin fragment CH-296 may improve transduction efficiency. Alternatively, low-speed centrifugation of vector-containing supernatant onto culture vessels may improve transduction efficiency in the absence of CH-296 preloading. Using the NIH/3T3-derived Moloney murine leukemia virus-based packaging cell lines PG13, PA317, and PT67, we here show that preloading by low-speed centrifugation improves transduction efficiency in a packaging cell subclone-dependent manner. Preloading by centrifugation, however, cannot generally replace CH-296 and we obtained the overall highest transduction levels when combining centrifugation and CH-296 precoating. We found, moreover, that the factor responsible for high susceptibility to preloading in our PG13-derived vector supernatant was transferable to a PA317-derived vector supernatant with low susceptibility to preloading. Furthermore, our PA317, PG13, and PT67 subclones shed into their supernatants variable amounts of fibronectin. This soluble fibronectin formed aggregates of various sizes and generated complexes with vector particles. The fibronectin-vector complexes readily sedimented onto culture vessels and copurified after fibronectin-specific affinity purification of vector-containing supernatants. Finally, vector supernatant from 293T cells, which barely produce fibronectin, was not susceptible to preloading. The susceptibility to preloading by centrifugation thus appears to be dependent both on the specific packaging cell line and on the association of vector particles and packaging cell-produced fibronectin. Rigorous screening of individual vector-containing supernatants is therefore required to identify optimal transduction conditions for retroviral gene transfer.
逆转录病毒载体介导的基因转移已成功应用于临床基因治疗。然而,造血谱系的细胞仍然难以转导,尽管用纤连蛋白片段CH-296预包被培养容器可能会提高转导效率。另外,在没有CH-296预加载的情况下,将含载体的上清液低速离心到培养容器上可能会提高转导效率。使用源自NIH/3T3的基于莫洛尼鼠白血病病毒的包装细胞系PG13、PA317和PT67,我们在此表明低速离心预加载以包装细胞亚克隆依赖性方式提高转导效率。然而,离心预加载通常不能替代CH-296,并且当将离心和CH-296预包被相结合时,我们获得了总体最高的转导水平。此外,我们发现,在我们源自PG13的载体上清液中对预加载高度敏感的因子可转移到对预加载敏感性低的源自PA317的载体上清液中。此外,我们的PA317、PG13和PT67亚克隆向上清液中分泌了不同量的纤连蛋白。这种可溶性纤连蛋白形成了各种大小的聚集体,并与载体颗粒形成复合物。纤连蛋白-载体复合物很容易沉淀到培养容器上,并在对含载体的上清液进行纤连蛋白特异性亲和纯化后共纯化。最后,几乎不产生纤连蛋白的293T细胞的载体上清液对预加载不敏感。因此,通过离心进行预加载的敏感性似乎既取决于特定的包装细胞系,也取决于载体颗粒与包装细胞产生的纤连蛋白的结合。因此,需要对各个含载体的上清液进行严格筛选,以确定逆转录病毒基因转移的最佳转导条件。